Alzheimer's Association Commits $2.2M to Fund Research on How Disease Affects Genders Differently
The funding will support nine projects investigating why Alzheimer's disease disproportionately affects women versus men.
New ADNI Project to Perform Whole-genome Sequencing of Alzheimer's Patients
NEW YORK (GenomeWeb News) – The Alzheimer's Association and the Brin Wojcicki Foundation yesterday announced a partnership aimed at obtaining the whole-genome sequences of people with AD.
Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.
The new guidelines mark the second publication in recent months to suggest that protein biomarkers be integrated into current definitions of Alzheimer's disease, though the new proposal explicitly calls for protein biomarkers to be used only in research settings.
NIA: Alzheimer's Biomarker Tests Suited for Research, Not Clinic
The National Institute on Aging /Alzheimer's Association Guidelines for Alzheimer's Disease sees biomarker use in the clinic as a future prospect.